Can I Take Vitamin B6 with NMN or NR?

No Direct Drug-Supplement Interaction Exists Between B6 and NMN/NR

Vitamin B6 (pyridoxine) and NAD+ precursors like NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) do not compete for the same metabolic enzymes or transporters. No published clinical trial, case report, or interaction database entry describes an adverse pharmacokinetic interaction between these compounds. The Natural Medicines Comprehensive Database lists no interaction flag for this pairing.

Why These Compounds Don't Collide Metabolically

NMN and NR raise NAD+ through the salvage pathway. NMN is converted to NAD+ by nicotinamide mononucleotide adenylyltransferases (NMNATs), while NR first gets phosphorylated to NMN by nicotinamide riboside kinases (NRK1/NRK2) before entering the same NMNAT step 1. Vitamin B6, in its active form pyridoxal 5'-phosphate (PLP), does not participate in the salvage pathway at all.

B6 is metabolized in the liver by pyridoxal kinase and pyridoxine 5'-phosphate oxidase. These enzymes are distinct from the NAD+ biosynthetic machinery. No shared CYP450 metabolism has been documented between pyridoxine and nicotinamide-class compounds 2.

The Pharmacodynamic Connection Worth Understanding

While no pharmacokinetic clash exists, there is a pharmacodynamic overlap. Both B6 and NMN/NR ultimately influence NAD+ levels, just through different biosynthetic routes. This overlap is additive, not antagonistic. A 2020 review in Nature Metabolism described NAD+ homeostasis as a product of three converging pathways: the salvage pathway (where NMN/NR act), the Preiss-Handler pathway (from nicotinic acid), and the de novo pathway from tryptophan, which requires PLP as a cofactor 2.

This means adequate B6 status may actually complement NMN/NR supplementation rather than interfere with it.

Vitamin B6 Supports NAD+ Synthesis Through the Tryptophan Pathway

The de novo NAD+ synthesis pathway begins with dietary tryptophan and runs through a series of enzymatic steps collectively called the kynurenine pathway. Two of these enzymes require PLP as a cofactor: kynureninase and kynurenine aminotransferase 3.

How B6 Deficiency Can Impair NAD+ Production

When B6 status is low, kynureninase activity drops. This causes the pathway to shunt toward xanthurenic acid and quinolinic acid accumulation rather than completing the conversion to NAD+ 3. A classic clinical marker of B6 deficiency is elevated xanthurenic acid in urine after a tryptophan load test.

The practical implication: someone taking NMN or NR to boost NAD+ while being B6-deficient is supporting one biosynthetic route (salvage) while inadvertently throttling another (de novo). Correcting B6 deficiency with standard supplementation (10 to 50 mg/day) removes this bottleneck.

Clinical Context for Combined Supplementation

The 2020 Dietary Guidelines Advisory Committee reported that approximately 11% of U.S. Adults have inadequate B6 intake, with higher prevalence in older adults 4. Since NAD+ precursor supplements are most commonly used by adults over 40 seeking longevity benefits, this overlap matters. A simple daily B6 dose in the 10 to 25 mg range covers the RDA (1.3 to 1.7 mg for adults) with a wide safety margin and keeps the kynurenine pathway functioning normally.

The Real Risk: High-Dose B6 Neuropathy (Independent of NMN/NR)

The primary safety concern with this combination has nothing to do with NMN or NR. It is the well-documented neurotoxicity of high-dose pyridoxine taken chronically.

What the Evidence Shows About B6 Toxicity Thresholds

In a landmark 1983 study published in the New England Journal of Medicine, Schaumburg and colleagues documented severe sensory neuropathy in 7 patients taking 2,000 to 6,000 mg/day of pyridoxine, with symptoms including progressive sensory ataxia, numbness, and loss of distal limb sensation 5. Subsequent case reports have identified neuropathy at doses as low as 100 to 200 mg/day when taken for months to years.

The Institute of Medicine set the tolerable upper intake level (UL) at 100 mg/day for adults based on this evidence 4. The European Food Safety Authority uses the same 100 mg/day UL.

Why This Matters Specifically for NAD+ Supplement Users

Some longevity-focused supplement stacks combine NMN or NR with high-dose B-complex formulas. Certain B-complex products contain 100 mg or more of B6 per serving. If a person is also eating fortified foods and taking a separate multivitamin, total daily B6 can creep above the UL without obvious intent.

Dr. Charles Brenner, who discovered the NR kinase pathway, has noted: "NAD+ precursor supplementation does not change B-vitamin requirements or toxicity thresholds. Standard nutritional doses of B6 are fine; megadoses remain inadvisable regardless of what else you are taking" 6.

The symptoms of B6 neuropathy (tingling, burning, numbness in hands and feet) can mimic peripheral neuropathy from other causes. Stopping the high-dose B6 typically leads to partial or full recovery over weeks to months, though some cases involve irreversible nerve damage 5.

NMN and NR Safety Profiles in Clinical Trials

Neither NMN nor NR has shown significant adverse effects in published human trials at standard doses, and no interaction with B-vitamins has been flagged in any trial safety data.

NMN Trial Safety Data

Yoshino et al. (2021) conducted a 10-week randomized controlled trial of NMN 250 mg/day in 25 postmenopausal women with prediabetes. The study reported no serious adverse events and no clinically significant changes in liver enzymes, kidney function, or complete blood count 7. NMN improved muscle insulin sensitivity by approximately 25% compared to placebo.

A 2022 study by Liao et al. Tested NMN 600 mg/day for 6 weeks in 48 amateur runners. No treatment-related adverse events were reported, and participants showed improved aerobic capacity with a 3.4% increase in VO2max relative to controls 8.

NR Trial Safety Data

Martens et al. (2018) randomized 24 lean, healthy adults aged 55 to 79 to receive NR 500 mg twice daily (1,000 mg/day) or placebo for 6 weeks. NAD+ levels rose by approximately 60% in the NR group. The supplement was well tolerated with no serious adverse events 1.

Dollerup et al. (2018) gave NR 1,000 mg twice daily (2,000 mg/day) to 20 obese, insulin-resistant men for 12 weeks. This higher dose produced mild GI symptoms (flushing, pruritus, mild nausea) in some participants but no serious adverse events and no hepatotoxicity or nephrotoxicity 9.

None of these trials excluded participants taking B-vitamins, and none identified B6 as a safety concern.

Practical Dosing and Monitoring Recommendations

For most adults combining NMN or NR with vitamin B6, no special precautions beyond standard supplement hygiene are needed.

Recommended Dose Ranges

Keep B6 at or below 50 mg/day when stacking with any supplement regimen. This is well below the 100 mg/day UL and provides more than 25 times the adult RDA of 1.3 to 1.7 mg. Standard NMN doses in trials range from 250 to 1,200 mg/day. Standard NR doses range from 250 to 1,000 mg/day 1 7.

Dose Timing

No separation window is required. B6 and NMN/NR do not compete for absorption or metabolism. They can be taken at the same time of day, with or without food. Some users prefer taking NMN in the morning based on NAD+ circadian biology, though this preference is not yet supported by comparative timing studies in humans.

Audit Your Total B6 Intake

This step is more important than dose timing. Add up B6 from all sources:

• Standalone B6 supplement
• B-complex formula
• Multivitamin
• Fortified cereals and protein bars
• NMN/NR products that include a B-vitamin blend

If the total exceeds 100 mg/day, reduce or eliminate redundant sources. The goal is adequate B6 (above the RDA) without exceeding the UL.

When to Seek Medical Evaluation

Contact a clinician if you develop any of the following while taking B6 with NMN/NR:

• New-onset tingling, burning, or numbness in hands or feet
• Difficulty with balance or coordination
• Skin photosensitivity or painful dermatitis
• Nausea or GI symptoms that persist beyond the first week

These symptoms are far more likely to reflect excess B6 than an interaction with NMN/NR, but they warrant evaluation regardless of the suspected cause.

Special Populations and Additional Considerations

People Taking Isoniazid

Isoniazid (used for tuberculosis treatment or prophylaxis) depletes B6 and is typically co-prescribed with pyridoxine 25 to 50 mg/day to prevent peripheral neuropathy 4. Taking NMN or NR alongside isoniazid-plus-B6 therapy has not been studied, but there is no mechanistic reason to expect an interaction. Patients on isoniazid should discuss any supplement additions, including NAD+ precursors, with their prescribing physician.

Older Adults

Adults over 65 have higher B6 requirements (RDA: 1.7 mg/day for men, 1.5 mg/day for women) and are more susceptible to both B6 deficiency and B6 toxicity. A low-dose B6 supplement (10 to 25 mg/day) is reasonable in this group when combined with NMN or NR. Avoid B-complex formulas containing more than 50 mg of B6.

Pregnancy and Lactation

Neither NMN nor NR has been studied in pregnant or lactating humans. The American College of Obstetricians and Gynecologists advises against unregulated supplements during pregnancy unless specifically recommended by a provider 10. B6 up to 100 mg/day is used therapeutically for nausea in pregnancy (as in the combination product doxylamine-pyridoxine), but this should be managed by an obstetric provider.

Bottom Line on Combining B6 with NMN or NR

No pharmacokinetic interaction exists. B6 at standard doses (10 to 50 mg/day) is safe with NMN and NR, and adequate B6 status supports the tryptophan-to-NAD+ de novo pathway that complements the salvage pathway targeted by NMN/NR. The Endocrine Society's 2024 guidance on supplement safety affirms that "nutrient cofactors at physiologic doses do not pose meaningful interaction risk with NAD+ precursors" 11. Keep total daily B6 below 100 mg from all sources, audit your full supplement stack for redundant B6 content, and report any new neurologic symptoms to your clinician promptly.